Search Results
Search results for "medicinal chemistry"
Results found for "medicinal chemistry"
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
Duke Distinguished Professor of Medicine and Biochemistry at Duke University, where he has led his laboratory Lefkowitz was awarded the Nobel Prize in Chemistry, shared with Brian Kobilka, for studies of G protein-coupled Lefkowitz learned at 5 AM on October 10, 2012, that he had won the Nobel Prize in Chemistry, his first Lefkowitz, M.D., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka . Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University
- Dr. Richard Premont | Dr. GPCR Ecosystem
Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University
- Dr. Richard Premont | Dr. GPCR Ecosystem
Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University
- Dr. Richard Premont | Dr. GPCR Ecosystem
Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University
- Dr. Richard Premont | Dr. GPCR Ecosystem
Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
Berchiche sets a welcoming tone as they dive into Ian’s unique academic journey—from early interests in medicine wraps with a playful exchange about possible podcast titles, with Yamina suggesting "Ancient Greek Chemistry
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
Panelists from InterAx Biotech, Rockefeller University, and the University of New Mexico — computational chemists homology modeling, coarse-grained molecular dynamics, and genetic code expansion for site-specific chemistry The experience of a seasoned medicinal chemist mentally docking a molecule from a 2D structure is not
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
machine learning, population genetics, and the clinical translation challenges that come with precision medicine hospital internship, Australia, and the decision to pursue science 13:06 - First exposure to computational chemistry Hauser Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
Pharmacology Course Coordinator Department of Pharmacology, University of North Carolina School of Medicine Kenakin trained in chemistry and pharmacology at the University of Alberta and completed postdoctoral
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines Why This Matters Translating basic GPCR science into actual medicines is broken. Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine. Ajay Yekkirala on the web Superluminal Medicines LinkedIn Tune in now to hear how asking “what if?” led Ajay Yekkirala to reshape the future of GPCR-targeted medicine. Unlock the Full Dr.
- Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem
Pharmacology Course Coordinator Department of Pharmacology, University of North Carolina School of Medicine Kenakin trained in chemistry and pharmacology at the University of Alberta and completed postdoctoral
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
are not the same thing - and the field had to prove it A long-standing assumption in both traditional medicine GPCR announcements 01:26 - Niv's career path - from theoretical chemistry in Russia and Israel to biotech Masha earned her Bachelor’s degree in chemistry, followed by a direct Ph.D. at the Institute of Chemistry Niv trained as a postdoctoral fellow at Weill Cornell Medical College.
- Dr. Sudha Shenoy | Dr. GPCR Ecosystem
Sudha Shenoy is currently an Associate Professor in Medicine & Cell Biology in the Division of Cardiovascular Medicine, Duke University Medical Center.
- Recombinant Antibodies for GPCRs: A Challenge to the Community | Dr. GPCR Ecosystem
He earned an M.D. from the University of Southern California School of Medicine and completed internal medicine training at California Pacific Medical Center in San Francisco. He transitioned from clinical medicine to academic research at UC Irvine, where he worked on protein
- FAQ | Dr. GPCR Ecosystem
These webinars are ideal for: GPCR pharmacologists Medicinal chemists working on receptor targets Structural
- Chris Langmead | Dr. GPCR Ecosystem
podcast list Strategic Partner(s) Chris Langmead Chris Langmead is Professor, Deputy Director, and Better Medicines Centre at the Monash Institute of Pharmaceutical Sciences (MIPS), a collaborative venture targeting new medicines
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
Maria Waldhoer at the Medical University of Graz, Austria, and received my Ph.D. in Molecular Medicine In 2015 I joined the University of Maryland School of Medicine as an Assistant Professor.
- Dr. Randy Hall | Dr. GPCR Ecosystem
Hall, Ph.D., is a Professor of Pharmacology and Chemical Biology in the Emory University School of Medicine Randy then joined the faculty at the Emory University School of Medicine in 1999. of research prizes, including the PhRMA New Investigator Award, the Distinguished Young Scholar in Medical
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
Paul Insel is Distinguished Professor of Pharmacology and Medicine at the University of California, San Insel also directs UCSD's MD-PhD Medical Scientist Training Program, a role he has held for over 30 years Insel's path from medicine to molecular pharmacology 05:15 The origin story — dinner with Al Gilman and During dinner with colleagues and Alfred Gillman , co-recipient of the 1994 Nobel Prize in Physiology or Medicine Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine the web UC San Diego Trejo Lab Wikipedia LinkedIn Google Scholar Orcid Twitter UC San Diego School of Medicine
- Dr. GPCR Board | Dr. GPCR Ecosystem
Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine the web UC San Diego Trejo Lab Wikipedia LinkedIn Google Scholar Orcid Twitter UC San Diego School of Medicine From 1995 to 2002, they worked at Yale University School of Medicine as the Bioinformatics Core Facility
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
which includes mathematics, signaling pathways, a wet lab for data generation, and AI and computational chemistry new CEO a year ago and the valuable contributions of Mark Levick, a former reviewer for the European Medicines
- Dr. Katarzyna Marcinkiewicz | Dr. GPCR Ecosystem
She obtained her Ph.D. from Weill Cornell Graduate School of Medical Sciences in New York City, studying During her postdoctoral training at New York University School of Medicine, her research focused on cellular
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
2020 to begin his own laboratory in the Department of Biochemistry at the University of Utah School of Medicine
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
Bedside Vision Ben’s work seeks to merge in vitro mechanistic data with in vivo efficacy , guiding medicinal chemists toward creating druggable PAMs .
- Dr. Juan José Fung | Dr. GPCR Ecosystem
Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr.
- GPCR Webinars | Dr. GPCR Ecosystem
Any scientist working with GPCRs — pharmacologists, medicinal chemists, cell biologists, translational
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
Benjamin Myers Ben Myers is an assistant professor at the University of Utah School of Medicine in Salt


























